Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects

NCT01519531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Safety

Interventions

DRUG: Placebo
DRUG: VIA-3196

Sponsor

Madrigal Pharmaceuticals, Inc.